Testosterone Levels May Be Determined in Childhood

Testosterone Levels May Be Determined in Childhood

estosterone levels in men may be determined by childhood environment rather than genetics, according to new study findings published in Nature Ecology & Evolution. Kesson...

 Enzalutamide Delays Metastasis in CRPC

Enzalutamide Delays Metastasis in CRPC

Enzalutamide, an androgen receptor inhibitor, delays metastasis in men with non-metastatic, castration-resistant prostate cancer (CRPC) and a rapidly rising PSA level, according...

 Metformin Added to Prostate Cancer ADT Ups Survival

Metformin Added to Prostate Cancer ADT Ups Survival

Metformin use is associated with prolonged survival among men with advanced prostate cancer receiving androgen deprivation therapy (ADT), according to a new study. In a study...

Conservative Management Up for Low-Risk Prostate Cancer in Veterans

Conservative Management Up for Low-Risk Prostate Cancer in Veterans

(HealthDay News) -- Among US veterans with low-risk prostate cancer, use of conservative management increased from 2005 to 2015, according to a research letter published online...

 Focal HIFU Effective Over 5 Years for PCa

Focal HIFU Effective Over 5 Years for PCa

Patients who undergo focal therapy for prostate cancer (PCa) using high-intensity focused ultrasound (HIFU) experience good survival over 5 years, according to new study...

 Advanced Prostate Cancer Variant More Common Than Thought

Advanced Prostate Cancer Variant More Common Than Thought

(HealthDay News) -- The incidence of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) is 17% among patients with metastatic castration-resistant prostate...

Prostate Cancer ADT Ups Thromboembolic Event Risk

Prostate Cancer ADT Ups Thromboembolic Event Risk

Androgen deprivation therapy (ADT) for prostate cancer can increase the risk of thromboembolic events, according to a recent systematic review and meta-analysis published online...

Trimodal Therapy and RC for MIBC Offer Similar Survival

Trimodal Therapy and RC for MIBC Offer Similar Survival

Trimodal therapy (TMT) and radical cystectomy (RC) yield similar survival outcomes for patients with non-metastatic muscle-invasive bladder cancer, according to a new systematic...

FDA Approves Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

FDA Approves Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

The US Food and Drug Administration (FDA) approved enzalutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC) as well as...

PET/CT May Improve Imaging of Recurrent Prostate Cancer

PET/CT May Improve Imaging of Recurrent Prostate Cancer

Positron emission tomography (PET)-based imaging may offer a promising alternative to conventional imaging for characterizing the true extent of disease in men who experience...

Aggressive Therapy Warranted for Gleason 10 Prostate Cancer

Aggressive Therapy Warranted for Gleason 10 Prostate Cancer

Aggressive therapy with curative intent appears to be highly successful in men with Gleason score (GS) 10 prostate cancer (PCa), according to a new study published in the...

Experimental Test Detects Endometrial and Ovarian Cancers

Experimental Test Detects Endometrial and Ovarian Cancers

Researchers have shown that an experimental screening test can detect some endometrial and ovarian cancers at their early, more treatable stages. The test, called PapSEEK, is a...